SE (NASDAQ:ARGX – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-two analysts that are ...

Analysts at Wedbush lifted their Q4 2024 EPS estimates for shares of argenx in a report released on Monday, January 13th.

Novartis is putting $20 million upfront into a near-$1 billion deal with US start-up Lindy Biosciences that aims to convert biologic drugs delivered by infusion into therapies that can be self ...

A subcutaneous (SC) injection version of Roche’s big-selling multiple sclerosis therapy Ocrevus has matched the current intravenous form in a clinical trial and, according to the company, could ...

Efgartigimod alfa is under clinical development by Argenx and currently in Phase III for Dermatomyositis. According to GlobalData, Phase III drugs for Dermatomyositis have a 20% phase transition ...

(Nivolumab + relatlimab) is under clinical development by Bristol-Myers Squibb and currently in Phase II for Merkel Cell Carcinoma. According to GlobalData, Phase II drugs for Merkel Cell Carcinoma ...

Federal Workers Told to Inform on Colleagues Trying to Evade D.E.I. Crackdown Justice Department orders a halt to civil rights work. Budget nominee hints at work requirements for Medicaid.

Ukrainian forces described a different kind of enemy, fighting with unfamiliar tactics and little option to retreat. By Marc Santora and Helene Cooper Rupert Murdoch’s News Group Newspapers ...

The Food and Drug Administration has determined that it is necessary for manufacturers of cat and dog foods who are covered by the FDA Food Safety Modernization Act Preventive Controls for Animal ...

One in 12 children globally faces online sexual abuse: Lancet study Approximately one in 12 children worldwide experienced online sexual abuse in the past year, according to a study published in ...